CTD T 6.25/80 TAB 15.S

About

CTD T 6.25/80 is a combination medication specifically formulated for the effective management of hypertension. It combines a thiazide-like diuretic (Chlorthalidone) with an angiotensin receptor blocker (Telmisartan). Chlorthalidone works by increasing the excretion of sodium and water from the body through the kidneys, which helps to reduce blood volume and consequently lowers blood pressure. Telmisartan, on the other hand, acts by blocking the effects of angiotensin II, a potent hormone that causes blood vessels to narrow. By blocking angiotensin II, Telmisartan relaxes blood vessels, leading to vasodilation and a further reduction in blood pressure. This dual mechanism of action provides comprehensive and sustained blood pressure control, making it particularly effective for patients who require more than one medication to achieve their target blood pressure, thereby reducing the overall risk of cardiovascular disease.

Uses

• Treatment of essential hypertension.
• Reduction of cardiovascular risk in high-risk patients.
• Management when monotherapy is insufficient.
• Long-term blood pressure control.

Directions For Use

Take one tablet orally once daily, with or without food, at the same time each day, as directed by your physician.

Benefits

• Effective and sustained blood pressure control.
• Reduces the risk of cardiovascular events.
• Manages fluid retention and edema.
• Provides synergistic antihypertensive action.
• Convenient once-daily dosing.
• Protects target organs from hypertension damage.

Side Effects

• Dizziness or lightheadedness.
• Headache.
• Fatigue or weakness.
• Orthostatic hypotension.
• Electrolyte imbalances (e.g., low potassium).
• Muscle cramps.
• Dry mouth.
• Increased urination.
• Abdominal pain or nausea.
• Back pain.
• Cough (less common than ACEIs).
• Insomnia.

Safety Measures

• Alcohol - Avoid or limit alcohol consumption as it can enhance the blood pressure-lowering effect, leading to increased dizziness and lightheadedness.
• Pregnancy - Contraindicated during pregnancy, especially in the second and third trimesters, due to the ARB component's potential for severe fetal harm.
• Breastfeeding - Not recommended during breastfeeding as components can pass into breast milk and may pose risks to the infant. Consult your doctor.
• Liver - Use with caution in patients with liver impairment, as dose adjustments may be necessary. Monitor liver function regularly.
• Kidney - Dose adjustment is required in patients with kidney impairment. Monitor renal function closely, especially in severe cases, due to the diuretic and ARB components.
• Lung - No specific direct adverse effects on lung conditions are typically associated with this combination, but general caution applies for severe underlying respiratory issues.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.